Insiders Dimerix Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:11:03 2024-06-07 am EDT			5-day change	1st Jan Change
0.575 ^AUD	+6.48%		+16.16%	+180.49%

May. 29	Euroz Hartleys Adjusts Dimerix’s Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy	MT
May. 27	Dimerix Signs License Deal for Kidney Disease Medication in the Middle East	MT

Dimerix Limited Announces Appointment of Mark Diamond as Director	Nov. 30	CI
Dimerix Appoints Nonexecutive Chair	Nov. 19	MT
Dimerix Appoints Medical Chief	23-10-22	MT
Dimerix Limited Announces Appointment of Dr David Fuller as Chief Medical Officer	23-10-22	CI
Dimerix Secures Conditional US FDA Clearance for Kidney Medication Brand Name	23-09-25	MT
Dimerix Limited Appoints Clinton Snow New Non-Executive Director to the Board, Effective 01 May 2023	23-04-30	CI
Dimerix Non-Executive Chairman Resigns	22-12-22	MT
Dimerix Names New Chief Medical Officer	22-02-06	MT
Dimerix Limited Appoints Dr. Ash Soman as Chief Medical Officer	22-02-06	CI
Dimerix Limited Announces the Resignation of David Franklyn as Non- Executive Director	19-10-10	CI
Dimerix Limited Announces Management Changes	18-08-26	CI
Dimerix Limited Announces Management Changes	18-04-29	CI
Dimerix Limited Appoints David Packham as Chief Medical Officer	18-03-26	CI
Dimerix Limited Appoints Medical Advisory Board	17-10-17	CI
Dimerix Ltd Appoints Kathy Harrison as its Inaugural Full Time Chief Executive Officer	17-08-01	CI
Dimerix Limited Appoints Hugh Alsop as Non-Executive Director	17-04-30	CI
Dimerix Limited Appoints Kathy Harrison as Chief Executive Officer	16-11-06	CI
Dimerix Announces the Resignation of Elizabeth Jazwinska as Director	16-11-03	CI
Dimerix Limited Appoints Liz Jazwinska as Non-Executive Director	15-12-16	CI
Sun Biomedical Announces Executive Changes	15-11-23	CI

No results for this search